The American Association of Clinical Chemistry (AACC) has announced that Loretta L. Doan, PhD, has assumed the position of Vice President of Policy and Global Affairs. Prior to joining AACC, Dr. Doan served as Director of Science Policy at the Endocrine Society, an organization representing more than 18,000 scientists and clinicians. At the Endocrine Society, she led a diverse portfolio of science policy initiatives that advanced the field of endocrinology, including a program focused on the standardization of hormone assays.
In her role at AACC, Dr. Doan will primarily be responsible for leading AACC’s science policy and advocacy efforts, which in 2014 involved issues ranging from funding for newborn screening to the U.S. Food and Drug Administration’s proposal to regulate laboratory-developed tests. Dr. Doan will also work to build the association’s global presence and enhance the visibility of the field of laboratory medicine and its practitioners.
“Dr. Doan has a unique skill set that combines strong scientific credentials with extensive experience in public policy and communicating scientific content and concepts to a range of audiences,” said AACC CEO Janet B. Kreizman. “With her proven ability to design and advance public policy initiatives, we are confident that she will be a strong asset in AACC’s effort to promote greater public understanding of laboratory tests, and to ensure that laboratory medicine professionals are heard when health and science policy issues are being addressed.”
“It is a privilege to have been selected as AACC’s Vice President of Policy and Global Affairs,” said Dr. Doan. “I look forward to working with AACC staff and members, both in the United States and internationally, to build awareness of the essential contribution of laboratory medicine professionals to improving patient outcomes through effective laboratory testing, diagnosis, and treatment.”
Dr. Doan joined the Endocrine Society in 2006 to serve as the organization’s Manager of Science Policy, and launched the society’s first science policy program before being appointed Associate Director of Science Policy in 2008 and Director of Science Policy in 2011. Prior to the Endocrine Society, Dr. Doan completed a 2-year postdoctoral fellowship in the Experimental Immunology Branch of the National Cancer Institute at the National Institutes of Health.
Dr. Doan earned her PhD in biochemistry and molecular biology from the University of Louisville, Kentucky. ■